The clinical value of non-curative resection followed by chemotherapy for incurable gastric cancer

World Journal of Surgery

Volumn 36, Issue 8, 2012, Pages 1800-1805

  Ko, Kyung Jai ^a   Shim, Jung Ho ^a   Yoo, Han Mo ^a   Il, Seong O ^a   Jeon, Hae Myung ^a   Park, Cho Hyun ^a   Jeon, Dong Jin ^a   Song, Kyo Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CHI SQUARE DISTRIBUTION; FEMALE; GASTRECTOMY; HUMAN; LENGTH OF STAY; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PALLIATIVE THERAPY; PATHOLOGY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; STATISTICS; STOMACH TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866737034     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1566-4     Document Type: Article

References (15)

1. Park CH, Song KY, Kim SN (2008) Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol 34:36-41
2. Miner TJ, Jaques DP, Tavaf-Motamen H et al (1999) Decision making on surgical palliation based on patient outcome data. Am J Surg 177:150-154
3. Bozzetti F, Bonfanti G, Audisio RA et al (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164:151-154
4. Haugstvedt T, Viste A, Eide GE et al (1989) The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 13:617-621. doi:10.1007/BFO1658884
5. Meijer S, De Bakker OJ, Hoitsma HF (1983) Palliative resection in gastric cancer. J Surg Oncol 23:77-80
6. Monson JR, Donohue JH, McIlrath DC et al (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68:1863-1868
7. Ouchi K, Sugawara T, Ono H et al (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69:41-44
8. Strong VE, Song KY, Park CH et al (2010) Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 251:640-646
9. World Health Organization (1990) Cancer pain relief and palliative care: report of a WHO expert committee. 11: Technical Report Series No. 804, Geneva, World Health Organization
10. McCarter MD, Fong Y (2001) Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 8:38-43
11. Pollock RE, Roth JA (1989) Cancer-induced immunosuppression: implication for therapy? Semin Surg Oncol 5:414-419
12. Jeung HC, Rha SY, Jang WI et al (2002) Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg 89:460-466
13. Bang YJ, van Cutsem E, Feyereislova A, the ToGA Trial Investigators et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687-697
14. Selby PJ, Chapman J-AW, Etazadi-Amoli J et al (1984) The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13-22
15. Fujitani K, Yang HK, Kurokawa Y et al (2008) Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single noncurable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol 38:504-506